Loading…
Astrana Health, Inc. is projected to rise to $61.57 by 2027, a +31% move from its current price of $46.88. ASTH is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $45.90 | $46.91 | $47.93 | +0.07% |
| Jul 14 | $45.52 | $46.94 | $48.39 | +0.13% |
| Jul 15 | $45.24 | $46.97 | $48.76 | +0.20% |
| Jul 16 | $45.01 | $47.00 | $49.07 | +0.26% |
| Jul 17 | $44.81 | $47.03 | $49.36 | +0.33% |
| Jul 18 | $44.63 | $47.06 | $49.62 | +0.39% |
| Jul 19 | $44.47 | $47.09 | $49.86 | +0.46% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $44.47 | $47.09 | $49.86 | +0.46% |
| Week 2 | $43.63 | $47.31 | $51.29 | +0.92% |
| Week 3 | $43.04 | $47.52 | $52.47 | +1.38% |
| Week 4 | $42.58 | $47.74 | $53.52 | +1.85% |
| Week 5 | $42.20 | $47.96 | $54.50 | +2.31% |
| Week 6 | $41.88 | $48.18 | $55.42 | +2.78% |
| Week 7 | $41.60 | $48.40 | $56.30 | +3.25% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Astrana Health, Inc. is a healthcare management company that provides medical care services in the United States.
The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.
Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc.
and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.
Astrana Health, Inc. (ASTH) is a Healthcare company currently trading at $46.28 per share with a market capitalization of $2.29B. It is ranked 1943 in market position.
The asset blends a healthcare management focus with a U.S. footprint, reflecting its three-segment structure and care coordination services across patients, families, physicians, hospitals, and health plans. The current price is supported by a positioning that the market cap and rank imply, with additional technical context available below.
Technical indicators place the stock in a context of upside potential, and a long-run forecast suggests an upward price trajectory across multiple years, culminating in substantial upside by 2050. The forecast provides year-by-year expectations for value, with varying degrees of bullishness across the horizon.
A major floor 50.4% below — a decisive break under it would weaken the trend.
The nearest floor, 21.7% below — buyers have tended to step in here.
The nearest ceiling, 6.3% above — a clean break opens room to run.
A major ceiling 22.8% above — clearing it would confirm fresh momentum.
Key ASTH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ASTH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $46.78 | Buy | $46.83 | Buy |
| MA 10 | $46.88 | Sell | $46.10 | Buy |
| MA 20 | $43.40 | Buy | $44.16 | Buy |
| MA 50 | $39.90 | Buy | $39.89 | Buy |
| MA 100 | $32.81 | Buy | $35.48 | Buy |
| MA 200 | $29.39 | Buy | $32.24 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 67.35 | Neutral |
| Stoch RSI (14) | 20.53 | Neutral |
| CCI (20) | 66.38 | Neutral |
| Williams %R (14) | -28.67 | Info |
| MACD (12,26,9) | 0.12 | Buy |
| ROC (12) | 13.79 | Buy |
| Bollinger %B (20,2) | 0.73 | Neutral |
| Stochastic %K (14) | 71.33 | Neutral |
| TRIX (15) | 0.85 | Buy |
| Awesome (5,34) | 5.64 | Buy |
| Ultimate (7,14,28) | 62.02 | Neutral |
| Momentum (10) | 3.38 | Buy |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 46.41 | Buy |
| ADX (14) | 38.31 | Buy |
| ATR (14) | 0.86 | Info |
The 30-day picture shows a range from $39.80 to $53.82, which frames a directional setup over the near term.
RSI14 is 70, indicating near-overbought conditions on a short horizon, while the price-trend backdrop is supported by a 50-day simple moving average of $39.40 and a 200-day simple moving average of $29.20. Aiding the setup, the stock has a documented support at $36.70 and resistance at $49.81.
Overall, the technical sentiment is BULLISH, suggesting potential for continued upside into the near term given the current range and moving-average alignment.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $18.16 | $46.88 | $67.38 | 0% | Neutral | |
| $49.96 | $61.57 | $79.65 | +31% | Bullish | |
| $60.26 | $75.88 | $101.17 | +62% | Bullish | |
| $67.54 | $86.57 | $118.20 | +85% | Bullish | |
| $80.12 | $104.31 | $145.30 | +123% | Bullish | |
| $103.64 | $136.86 | $194.03 | +192% | Bullish | |
| $115.88 | $155.04 | $223.31 | +231% | Bullish | |
| $132.23 | $179.11 | $261.70 | +282% | Bullish | |
| $148.30 | $203.23 | $300.91 | +334% | Bullish | |
| $151.06 | $209.32 | $313.77 | +347% | Bullish | |
| $265.68 | $386.91 | $610.97 | +725% | Bullish | |
| $518.84 | $821.47 | $1,400.55 | +16.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $18.16 | $46.88 | $57.05 | +0.00% |
| August 2026 | $42.09 | $49.40 | $59.33 | +5.38% |
| September 2026 | $42.16 | $49.75 | $60.29 | +0.72% |
| October 2026 | $43.46 | $51.53 | $62.92 | +3.58% |
| November 2026 | $45.29 | $53.92 | $66.25 | +4.63% |
| December 2026 | $45.63 | $54.53 | $67.38 | +1.13% |
Click any year to see its month-by-month ASTH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ASTH to range from $18.16 to $67.38 through 2026. The $46.88 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The ASTH price prediction for 2027 points to an average of $61.57 (low $49.96, high $79.65) — a potential gain of +31% on today's $46.88. Momentum favours further upside here.
In 2028, ASTH is projected to trade between $60.26 and $101.17, averaging $75.88 — a potential gain of +62% from today's $46.88. That is up +23% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Astrana Health, Inc.'s 2029 outlook centres on $86.57, within a $67.54 to $118.20 range. That is up +14% on the projected 2028 average. That marks a +85% change versus current levels. Momentum favours further upside here.
By 2030, ASTH could reach as high as $145.30, with a base case around $104.31 and support toward $80.12 — roughly +123% from $46.88. Buyers look set to stay in control over this stretch.
Expect ASTH to range from $103.64 to $194.03 through 2031. The $136.86 average target implies a +192% move from current prices. That is up +31% on the projected 2030 average. Momentum favours further upside here.
The ASTH price prediction for 2032 points to an average of $155.04 (low $115.88, high $223.31) — a potential gain of +231% on today's $46.88. Buyers look set to stay in control over this stretch.
In 2033, ASTH is projected to trade between $132.23 and $261.70, averaging $179.11 — a potential gain of +282% from today's $46.88. That is up +16% on the projected 2032 average. Momentum favours further upside here.
Astrana Health, Inc.'s 2034 outlook centres on $203.23, within a $148.30 to $300.91 range. That is up +13% on the projected 2033 average. That marks a +334% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, ASTH could reach as high as $313.77, with a base case around $209.32 and support toward $151.06 — roughly +347% from $46.88. Momentum favours further upside here.
Expect ASTH to range from $265.68 to $610.97 through 2040. The $386.91 average target implies a +725% move from current prices. That is up +85% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The ASTH price prediction for 2050 points to an average of $821.47 (low $518.84, high $1,400.55) — a potential gain of +16.5x on today's $46.88. Momentum favours further upside here.
Investing $1,000 in ASTH today (≈ 21.333333 ASTH) could be worth
$17,524.71
+$16,524.71 (+1652%) by 2050 · US Dollar
Based on the average projected ASTH price of $821.47 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ASTHwould be worth at today's price.
$1,000 invested in ASTH on Jul 10, 2025 (≈ 39.047246 ASTH) would be worth
$1,830.34
+$830.34 (+83.0%) today · 1.83× · US Dollar
Based on a ASTH entry price of $25.61 vs. today's $46.88.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $49.17 | $953.33 | -4.7% |
| 1 month ago | $38.73 | $1,210.3 | +21.0% |
| 3 months ago | $27.63 | $1,696.53 | +69.7% |
| 6 months ago | $29.21 | $1,604.76 | +60.5% |
| 1 year ago | $25.61 | $1,830.34 | +83.0% |
| All time (5.0y) ago | $79.02 | $593.2 | -40.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ASTH forecast.
Our base-case forecast reaches $94.00 around 2030.
Implied market cap at $94.00: $4.66B
The multi-year forecast maps a clear upward trajectory for Astrana Health, with the avg price rising from $46.28 in 2026 to higher levels across the horizon. In 2026 the avg is $46.28 with a neutral sentiment and 0% ROI.
By 2027, the avg rises to $60.73 with a bullish sentiment and a 31.2% ROI. In 2028 the avg is $75.00 and the ROI climbs to 62.1%. The 2029 forecast shows an avg of $85.35 with an 84.4% ROI, and 2030 projects an avg of $103.67 with a 124% ROI.
Beyond 2030, the path continues higher: 2031 avg $136.67 (ROI 195.3), 2032 avg $153.57 (ROI 231.8), 2033 avg $177.77 (ROI 284.1), 2034 avg $201.56 (ROI 335.5), 2035 avg $205.78 (ROI 344.6).
The long-run horizon shows especially strong upside by 2040 with an avg of $383.84 and a 729.4% ROI, and by 2050 with an avg of $815.07 and a 1661.2% ROI. Across years, the sentiment remains BULLISH as prices are forecast to move higher, though these are estimates and not guarantees.
Tap a question to reveal the answer.
The 2030 average forecast is $103.67, with a minimum of $78.99 and a maximum of $145.86; the forecasted ROI is 124 and the sentiment is BULLISH.
The forecast shows bullish sentiment for most years after 2026, with the average price rising to $103.67 in 2030 and to $815.07 by 2050, corresponding to a 124% ROI in 2030 up to 1,661.2% by 2050, though 2026 is neutral with an average of $46.28 and 0% ROI.
Yes. The 2030 forecast lists an average of $103.67, with a min of $78.99 and a max of $145.86, indicating a path that can cross the $100 mark under the projected range.
The current price is $46.28.
The 2050 forecast shows an average of $815.07, a minimum of $503.26, a maximum of $1,416.00, and a ROI of 1661.2, with a bullish sentiment.
Astrana Health, Inc. Community Discussion
0Share your Astrana Health, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.